NervGen Pharma Recognized As A Top 50 TSX Venture Exchange Company
VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, has been recognized by… Read More




